Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Our aim is to support clinical research in primary care and to advance the way we answer clinical questions using statistics to improve healthcare worldwide.

Medical statisticians teaching on the Evidence-Based Healthcare course. © John Cairns
Medical statisticians teaching on the Evidence-Based Healthcare course.

We are a team of statisticians, systematic reviewers, methodologists and health economists who are involved in a variety of research programmes using a wide range of expertise to develop innovative methods of analysis and monitoring in primary and secondary research, including diabetes, oral anticoagulation therapy, hypertension, cardiovascular disease and chronic kidney disease.

Professor Perera, Director of the Medical Statistics Group, has overseen the development of one of the strongest methodological/statistical groups in the UK (across all clinical areas) with a particular emphasis on monitoring, with the group achieving national and international recognition [NIHR Progress Report 2008/09-Delivering Health Research].

The team of also provides support for the design, execution and analysis of studies to all the clinical research groups in the department as well as our own individual research programmes. We are closely involved in:

Clinical trials

We provide support to the Primary Care Clinical Trials Unit with statisticians embedded within the Trials Unit. We specialise in primary care trials and in particular the design and analysis of cluster trials.

Teaching

Our group is heavily involved in teaching of both undergraduate and graduate programmes. In particular, many of our senior members act as supervisors for both the MSc in EBHC and for both of our DPhil programmes. Professor Perera also teaches for Cochrane UK.

Our team

Blog posts

Was it possible to predict the areas most vulnerable to the negative impacts of COVID-19?

Stuart Redding and Catia Nicodemo, from the Centre for Health Service Economics and Organisation, describe a simple metric that predicts which English CCG regions are most vulnerable.

Ranin Soliman: evidence resonates with qualitative research

Ranin Soliman, DPhil Student in EBHC, describes her experiences of the qualitative research methods module.

Latest news:

Study provides new estimates of breast cancer risks associated with HRT

Results add to existing knowledge and should help doctors and women make the best treatment choices

New risk model estimates likelihood of hospitalisation or death from COVID-19

A new risk model, developed by UK researchers to predict a person’s risk of being admitted to hospital and dying from Covid-19 has been published by The BMJ

Updated Cochrane Review shows electronic cigarettes can help people quit smoking but more evidence is needed on long-term harms

Newly updated Cochrane evidence published today in the Cochrane Library finds that electronic cigarettes containing nicotine could increase the number of people who stop smoking compared to nicotine replacement therapy – such as chewing gum and patches – and compared to no treatment, or electronic cigarettes without nicotine. More information is needed on harms.